Overall rank by patents
#32,928
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Premier Biotech, Llc
USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).
8
Total patents granted
3
CPC technology areas
10.4
Avg claims per patent
-40%
5-year filing velocity
The verdict
Premier holds 8 US patents across 3 technology areas, rank #32,928 of 50,000 tracked assignees.
- #32,928
- of 50,000 US assignees by volume
- Top 94%
- by Innovation Score (19.9/100)
- 10.4
- avg claims per patent
- -40%
- filing velocity, last 5 yrs
Portfolio overview
Premier Biotech, Llc has been granted 8 US utility patents between 2015 and 2025, placing Premier Biotech, Llc at rank #32,928 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.4 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a US Corporation, Premier Biotech, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Premier sits between Poynting Antennas (pty) Limited (8 patents, rank #32,924) and Presspart Gmbh &co. KG (8 patents, rank #32,932) - the closest US assignees by grant volume. The composite Innovation Score of 19.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 5 in the 2015–2019 window, a -40% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Premier Biotech, Llc's 10.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Premier Biotech, Llc against peers pursuing similar technology classes.
Who files at Premier's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Poynting Antennas…
Poynting Antennas (PTY) Limited
8 patents
- Prana Biotechnolo…
Prana Biotechnology Limited
8 patents
- Precision Fabrics…
Precision Fabrics Group, Inc.
8 patents
- Precision Rail an…
Precision Rail and Mfg., Inc.
8 patents
- Premier Print & S…
Premier Print & Services Group, Inc.
8 patents
- Presidium USA
Presidium USA, Inc
8 patents
- Pressio
Pressio Inc.
8 patents
- Presspart & KG
Presspart GmbH &Co. KG
8 patents
- Premier Biotech ◀
Premier Biotech, LLC
8 patents
What this shows Premier holds 8 patents at rank #32,928, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Premier
By rank, the assignees closest to #32,928 in granted patent volume.
- Poynting Antennas (pty) Limited #32,924 · 8 patents
- Prana Biotechnology Limited #32,925 · 8 patents
- Precision Fabrics Group, Inc. #32,926 · 8 patents
- Precision Rail And Mfg., Inc. #32,927 · 8 patents
- Premier Print & Services Group, Inc. #32,929 · 8 patents
- Presidium USA, Inc #32,930 · 8 patents
- Pressio Inc. #32,931 · 8 patents
- Presspart Gmbh &co. KG #32,932 · 8 patents
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in Premier's primary technology class.
- The Regents Of The University Of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson And Company 193 in class
- Bio-rad Laboratories, Inc. 174 in class
- President And Fellows Of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
Premier's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
20 Top 94% higher than 6% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 12.5% |
| 2016 | 1 | 12.5% |
| 2017 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2019 | 1 | 12.5% |
| 2020 | 1 | 12.5% |
| 2021 | 1 | 12.5% |
| 2025 | 1 | 12.5% |
Which technologies does Premier Biotech, Llc patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Premier Biotech, Llc hold?
Premier Biotech, Llc holds 8 US granted patents filed between 2015 and 2025, spanning 3 technology areas.
What is Premier Biotech, Llc's Innovation Score?
Premier Biotech, Llc has an Innovation Score of 19.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Premier Biotech, Llc focus on?
Premier Biotech, Llc's top technology area is B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE) with 4 patents. The company has filed patents in 3 CPC subclasses total.
Is Premier Biotech, Llc's patent filing rate increasing or decreasing?
Premier Biotech, Llc's recent filing velocity is -40% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Premier Biotech, Llc's patents?
Premier Biotech, Llc's patents average 10.4 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Premier Biotech, Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Premier's 8 grants land it in the top 94% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Premier ranks #32,928 of 50,000. Top 50 holders
- Most of this portfolio concentrates in B01L - see who else leads that technology area. B01L leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.